Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSavills Regulatory News (SVS)

Share Price Information for Savills (SVS)

Share Price is delayed by 15 minutes
Get Live Data
827.00    5.00 (0.61%)
Bid:
826.00
Ask:
828.00
Spread: 2.00 (0.242%)
Market Cap: £1.15b
SVS Live PriceLast checked at - London Stock Exchange

Intraday Savills Share Chart

AGM Statement

11 May 2022 09:56

RNS Number : 0942L
Savills PLC
11 May 2022
 

 

11 May 2022

SAVILLS PLC

("Savills" or "the Company")

Trading update

 

Ahead of its Annual General Meeting (AGM) to be held at 12 noon today at Savills, 33 Margaret Street, London W1G 0JD, Savills plc, the international real estate advisor issues the following trading update:

 

· Both our Transactional and Less Transactional businesses are performing in line with our expectations for the period to date

· The war in Ukraine, inflation and the rising interest rate cycle have somewhat tempered transactional activity, particularly in the smaller lot sizes both in terms of capital transactions and leasing take-up with activity skewed towards larger transactions

· Residential markets in the UK have performed well albeit stock availability continues to be significantly reduced compared with the equivalent prior year period

· Continued COVID and travel restrictions, particularly in Hong Kong and Mainland China have reduced activity in both the leasing and capital transaction markets

· Subject to exacerbation of current geopolitical risks and any potential further waves of COVID-related restrictions, the Board remains confident in its expectations for the full year

 

 

Mark Ridley, Chief Executive, commented:

 

"2022 has presented a number of heightened macro-economic, geopolitical, supply chain and, in some locations, continued COVID-related risks both to investors and corporates and to people's personal lives. I am delighted with the responses of our people and our clients specifically in respect of support for Ukraine, but also for their resilient approach to doing business in challenging circumstances. We have performed well so far this year and, with our strong balance sheet, we are continuing to undertake a variety of business development activities across the Group to further enhance our service to clients worldwide."

 

 

Trading Update

 

In the Asia Pacific region, the recovery has been most evident throughout the period in Singapore, Australia, Japan and Vietnam. Greater China, although below our original expectations for 2022, has performed resiliently in the face of continued significant COVID-related restrictions. Throughout the period, our substantial Property and Facilities Management business in the region has performed well.

 

In the UK, our performance has continued strongly, driven primarily by the continued high levels of activity in the transactional markets, albeit residential activity has, as anticipated, been somewhat lower than the unusually strong 2021 comparative period. Our less transactional service lines have performed in line with our expectations to date. Overall, the UK has traded slightly better than anticipated.

 

In Continental Europe and the Middle East, where Savills is more dependent upon transactional activity, performance has improved compared with both the prior period and our original expectations for the year to date, although we remain conscious that supply chain issues (particularly energy), inflation and the rising interest rate environment pose a challenge to a number of European economies.

 

In North America, where the Group is substantially dependent upon leasing activity by corporate occupiers, our business performance has been in line with our expectations and has improved significantly over the prior comparative period.

 

Savills Investment Management has traded in line with our expectations, albeit in an environment where a number of markets and sectors remain challenging for the deployment of equity capital. Debt markets have remained highly attractive for investors and DRC Savills has performed well to date.

 

 

Outlook

 

Savills has traded well so far in 2022. There remains significant investor interest in the secure income characteristics of real estate and occupiers are progressively focussing on improving the sustainability characteristics of their portfolios as well as creating environments in which staff can thrive. These positive trends stand against a backdrop of geopolitical, economic, practical (supply chain) and, in some cases, COVID-related challenges.

 

Whilst the Board is mindful of the backdrop, it remains confident in its expectations for 2022 as a whole.

 

We anticipate announcing the Group's Half Year Results for the six months to 30 June on 11th August 2022.

 

For further information, contact:

 

Savills 020 7409 8934

Mark Ridley, Group Chief Executive

Simon Shaw, Group Chief Financial Officer

 

Tulchan Communications 020 7353 4200

Mark Burgess

Elizabeth Snow

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMFIFVTEDILLIF
Date   Source Headline
19th Mar 20085:06 pmRNSDirector/PDMR Shareholding
18th Mar 200812:16 pmRNSDirector/PDMR Shareholding
14th Mar 20084:59 pmRNSHolding(s) in Company
14th Mar 20084:54 pmRNSHolding(s) in Company
12th Mar 20084:38 pmRNSDirector/PDMR Shareholding
12th Mar 20087:01 amRNSPreliminary Results
12th Feb 200812:26 pmRNSAdditional Listing
12th Feb 200812:05 pmRNSDirector/PDMR Shareholding
1st Feb 20089:22 amRNSTotal Voting Rights
1st Feb 20089:15 amRNSBlocklisting Interim Review
28th Jan 200810:37 amRNSHolding(s) in Company
11th Jan 20089:46 amRNSHolding(s) in Company
8th Jan 20087:00 amRNSTrading Statement
18th Dec 20075:28 pmRNSHolding(s) in Company
12th Dec 200710:42 amRNSDirector/PDMR Shareholding
30th Nov 20075:38 pmRNSHolding(s) in Company
26th Nov 20074:36 pmRNSHolding(s) in Company
26th Nov 200711:10 amRNSDirector/PDMR Shareholding
23rd Nov 20073:28 pmRNSDirector/PDMR Shareholding
22nd Nov 200712:00 pmRNSDirector/PDMR Shareholding
21st Nov 20075:03 pmRNSDirector/PDMR Shareholding
21st Nov 20075:02 pmRNSHolding(s) in Company
20th Nov 20074:47 pmRNSHolding(s) in Company
20th Nov 20074:40 pmRNSDirector/PDMR Shareholding
19th Nov 20072:29 pmRNSDirector/PDMR Shareholding
13th Nov 20075:49 pmRNSDirector/PDMR Shareholding
13th Nov 20071:49 pmRNSDirector/PDMR Shareholding
9th Nov 20074:36 pmRNSDirector/PDMR Shareholding
8th Nov 20074:54 pmRNSDirector/PDMR Shareholding
6th Nov 20075:10 pmRNSDirector/PDMR Shareholding
6th Nov 20074:46 pmRNSDirector/PDMR Shareholding
5th Nov 20074:58 pmRNSDirector/PDMR Shareholding
1st Nov 20075:29 pmRNSDirector/PDMR Shareholding
1st Nov 20075:14 pmRNSTotal Voting Rights
1st Nov 20075:00 pmRNSBlocklisting Interim Review
23rd Oct 20074:31 pmRNSHolding(s) in Company
18th Oct 20077:01 amRNSNew Chief Executive
11th Oct 20074:47 pmRNSDirector/PDMR Shareholding
13th Sep 200710:13 amRNSHolding(s) in Company
12th Sep 20073:27 pmRNSDirector/PDMR Shareholding
11th Sep 20077:01 amRNSInterim Results
10th Sep 200712:32 pmRNSHolding(s) in Company
14th Aug 20077:00 amRNSDirectorate Change
13th Aug 20075:41 pmRNSHolding(s) in Company
13th Aug 20075:30 pmRNSDirector/PDMR Shareholding
1st Aug 20074:28 pmRNSHolding(s) in Company
1st Aug 20072:17 pmRNSBlocklisting Interim Review
1st Aug 20077:02 amRNSUS Acquisition
23rd Jul 20072:47 pmRNSDirector/PDMR Shareholding
12th Jul 20075:13 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.